menu
    • menu
    [{"orgOrder":0,"company":"Mondego Bio","sponsor":"Biovance Capital","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"PORTUGAL","productType":"Miscellaneous","year":"2025","type":"Series A Financing","leadProduct":"ZE00-0388","moa":"PTPN2","graph1":"Oncology","graph2":"Preclinical","graph3":"Mondego Bio","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Mondego Bio \/ Biovance Capital","highestDevelopmentStatusID":"4","companyTruncated":"Mondego Bio \/ Biovance Capital"},{"orgOrder":0,"company":"Mondego Bio","sponsor":"ChemDiv","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2025","type":"Collaboration","leadProduct":"ZE00-0388","moa":"PTPN2","graph1":"Oncology","graph2":"Preclinical","graph3":"Mondego Bio","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Mondego Bio \/ Mondego Bio","highestDevelopmentStatusID":"4","companyTruncated":"Mondego Bio \/ Mondego Bio"}]

    Find Clinical Drug Pipeline Developments & Deals by Mondego Bio

    Menu

    Mondego Bio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Mondego Bio

                            Portugal arrow
                            CTAD25
                            Not Confirmed

                            Mondego Bio

                            Portugal arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ZE00-0388

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Recipient : ChemDiv

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            ChemDiv Extends Partnership with Mondego Bio on PTPN2 Immuno-Oncology Program

                            Details : The collaboration aims to advance ZE00-0388 in the treatment of cancer by targeting PTPN2.

                            Product Name : ZE00-0388

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            October 24, 2025

                            Lead Product(s) : ZE00-0388

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Recipient : ChemDiv

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Mondego Bio

                            Portugal arrow
                            CTAD25
                            Not Confirmed

                            Mondego Bio

                            Portugal arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ZE00-0388

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Biovance Capital

                            Deal Size : Undisclosed

                            Deal Type : Series A Financing

                            DEALS_DEV arrow-down

                            Biovance Capital leads Series A Financing in Mondego Bio

                            Details : The Portuguese start-up will use the proceeds to advance its oral cancer compound ZE00-0388, a selective blocker of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2).

                            Product Name : ZE00-0388

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            September 18, 2025

                            Lead Product(s) : ZE00-0388

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Biovance Capital

                            Deal Size : Undisclosed

                            Deal Type : Series A Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth